• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新加坡纵向老龄化研究 (SLAS) 风险指数的制定、验证和现场评估,用于预测轻度认知障碍和痴呆。

Development, Validation and Field Evaluation of the Singapore Longitudinal Ageing Study (SLAS) Risk Index for Prediction of Mild Cognitive Impairment and Dementia.

机构信息

A/P Tze Pin Ng, Department of Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Level 9, NUHS Tower Block, 1E Kent Ridge Road, Singapore 119228, Fax: 65-67772191, Email:

出版信息

J Prev Alzheimers Dis. 2021;8(3):335-344. doi: 10.14283/jpad.2021.19.

DOI:10.14283/jpad.2021.19
PMID:34101792
Abstract

BACKGROUND

Mild cognitive impairment (MCI) is a critical pre-dementia target for preventive interventions. There are few brief screening tools based on self-reported personal lifestyle and health-related information for predicting MCI that have been validated for their generalizability and utility in primary care and community settings.

OBJECTIVE

To develop and validate a MCI risk prediction index, and evaluate its field application in a pilot community intervention trial project.

DESIGN

Two independent population-based cohorts in the Singapore Longitudinal Ageing Study (SLAS). We used SLAS1 as a development cohort to construct the risk assessment instrument, and SLA2 as a validation cohort to verify its generalizability.

SETTING

community-based screening and lifestyle intervention Participants: (1) SLAS1 cognitively normal (CN) aged ≥55 years with average 3 years (N=1601); (2) SLAS2 cohort (N=3051) with average 4 years of follow up. (3) 437 participants in a pilot community intervention project.

MEASUREMENTS

The risk index indicators included age, female sex, years of schooling, hearing loss, depression, life satisfaction, number of cardio-metabolic risk factors (wide waist circumference, pre-diabetes or diabetes, hypertension, dyslipidemia). Weighted summed scores predicted probabilities of MCI or dementia. A self-administered questionnaire field version of the risk index was deployed in the pilot community project and evaluated using pre-intervention baseline cognitive function of participants.

RESULTS

Risk scores were associated with increasing probabilities of progression to MCI-or-dementia in the development cohort (AUC=0.73) and with increased prevalence and incidence of MCI-or-dementia in the validation cohort (AUC=0.74). The field questionnaire risk index identified high risk individuals with strong correlation with RBANS cognitive scores in the community program (p<0.001).

CONCLUSIONS

The SLAS risk index is accurate and replicable in predicting MCI, and is applicable in community interventions for dementia prevention.

摘要

背景

轻度认知障碍(MCI)是预防干预的关键痴呆前目标。基于自我报告的个人生活方式和与健康相关的信息,很少有简短的筛选工具可以预测 MCI,这些工具在初级保健和社区环境中的通用性和实用性尚未得到验证。

目的

开发和验证 MCI 风险预测指数,并在试点社区干预试验项目中评估其现场应用。

设计

新加坡纵向老龄化研究(SLAS)中的两个独立的基于人群的队列。我们使用 SLAS1 作为开发队列来构建风险评估工具,使用 SLA2 作为验证队列来验证其通用性。

地点

基于社区的筛查和生活方式干预

参与者

(1)年龄≥55 岁、认知正常(CN)的 SLAS1(N=1601);(2)SLAS2 队列(N=3051),随访平均 4 年。(3)在试点社区干预项目中,有 437 名参与者。

测量

风险指数指标包括年龄、女性、受教育年限、听力损失、抑郁、生活满意度、心血管代谢危险因素(宽腰围、糖尿病前期或糖尿病、高血压、血脂异常)数量。加权总分预测 MCI 或痴呆的概率。风险指数的自我管理问卷现场版本在试点社区项目中使用,并根据参与者的干预前认知功能进行评估。

结果

风险评分与发展队列中向 MCI 或痴呆进展的概率增加相关(AUC=0.73),与验证队列中 MCI 或痴呆的患病率和发病率增加相关(AUC=0.74)。社区计划中,现场问卷风险指数识别出高风险个体,与 RBANS 认知评分具有很强的相关性(p<0.001)。

结论

SLAS 风险指数在预测 MCI 方面准确且可复制,适用于社区痴呆预防干预。

相似文献

1
Development, Validation and Field Evaluation of the Singapore Longitudinal Ageing Study (SLAS) Risk Index for Prediction of Mild Cognitive Impairment and Dementia.新加坡纵向老龄化研究 (SLAS) 风险指数的制定、验证和现场评估,用于预测轻度认知障碍和痴呆。
J Prev Alzheimers Dis. 2021;8(3):335-344. doi: 10.14283/jpad.2021.19.
2
Predicting cognitive decline: Deep-learning reveals subtle brain changes in pre-MCI stage.预测认知衰退:深度学习揭示轻度认知障碍前阶段大脑的细微变化。
J Prev Alzheimers Dis. 2025 May;12(5):100079. doi: 10.1016/j.tjpad.2025.100079. Epub 2025 Feb 6.
3
Multi-domain interventions for the prevention of dementia and cognitive decline.多领域干预措施预防痴呆和认知能力下降。
Cochrane Database Syst Rev. 2021 Nov 8;11(11):CD013572. doi: 10.1002/14651858.CD013572.pub2.
4
18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).使用氟代甲磺酸去甲肾上腺素的18F正电子发射断层显像用于轻度认知障碍(MCI)患者中阿尔茨海默病性痴呆及其他痴呆的早期诊断。
Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012884. doi: 10.1002/14651858.CD012884.
5
Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI).用于检测轻度认知障碍(MCI)患者中阿尔茨海默病及其他痴呆症的简易精神状态检查表(MMSE)。
Cochrane Database Syst Rev. 2015 Mar 5;2015(3):CD010783. doi: 10.1002/14651858.CD010783.pub2.
6
18F PET with florbetapir for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).使用氟代硼吡咯进行18F正电子发射断层显像以早期诊断轻度认知障碍(MCI)患者的阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012216. doi: 10.1002/14651858.CD012216.pub2.
7
Psychological treatments for depression and anxiety in dementia and mild cognitive impairment.痴呆和轻度认知障碍患者的抑郁和焦虑的心理治疗。
Cochrane Database Syst Rev. 2022 Apr 25;4(4):CD009125. doi: 10.1002/14651858.CD009125.pub3.
8
Strong Relationship between Malnutrition and Cognitive Frailty in the Singapore Longitudinal Ageing Studies (SLAS-1 and SLAS-2).营养不良与认知衰弱在新加坡老龄化纵向研究 (SLAS-1 和 SLAS-2) 中的强相关性。
J Prev Alzheimers Dis. 2018;5(2):142-148. doi: 10.14283/jpad.2017.46.
9
Clinical judgement by primary care physicians for the diagnosis of all-cause dementia or cognitive impairment in symptomatic people.初级保健医生对有症状人群进行全因痴呆或认知障碍诊断的临床判断。
Cochrane Database Syst Rev. 2022 Jun 16;6(6):CD012558. doi: 10.1002/14651858.CD012558.pub2.
10
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).脑脊液tau蛋白及脑脊液tau蛋白与β淀粉样蛋白比值在轻度认知障碍(MCI)患者中用于诊断阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2.

引用本文的文献

1
Dementia and comorbidities in primary care: a scoping review.痴呆症与初级保健中的共病:范围综述。
BMC Prim Care. 2023 Dec 14;24(1):277. doi: 10.1186/s12875-023-02229-9.

本文引用的文献

1
Establishment of a Risk Prediction Model for Mild Cognitive Impairment among Elderly Chinese.建立中国老年人轻度认知障碍风险预测模型。
J Nutr Health Aging. 2020;24(3):255-261. doi: 10.1007/s12603-020-1335-2.
2
Validity and reliability of the Brazilian Portuguese version of the Australian National University - Alzheimer's Disease Risk Index (ANU-ADRI).澳大利亚国立大学阿尔茨海默病风险指数(ANU - ADRI)巴西葡萄牙语版本的效度和信度。
Dement Neuropsychol. 2018 Jul-Sep;12(3):235-243. doi: 10.1590/1980-57642018dn12-030003.
3
Frailty and Malnutrition: Related and Distinct Syndrome Prevalence and Association among Community-Dwelling Older Adults: Singapore Longitudinal Ageing Studies.
衰弱与营养不良:社区居住的老年人中相关且不同的综合征患病率及相关性:新加坡老龄化纵向研究。
J Am Med Dir Assoc. 2017 Dec 1;18(12):1019-1028. doi: 10.1016/j.jamda.2017.06.017. Epub 2017 Aug 10.
4
Modifiable Risk Factors for Prevention of Dementia in Midlife, Late Life and the Oldest-Old: Validation of the LIBRA Index.中年、老年和高龄老人痴呆症预防的可改变风险因素:天秤座指数的验证
J Alzheimers Dis. 2017;58(2):537-547. doi: 10.3233/JAD-161208.
5
Validating the role of the Australian National University Alzheimer's Disease Risk Index (ANU-ADRI) and a genetic risk score in progression to cognitive impairment in a population-based cohort of older adults followed for 12 years.在一个对老年人进行了12年随访的基于人群的队列中,验证澳大利亚国立大学阿尔茨海默病风险指数(ANU-ADRI)和遗传风险评分在进展为认知障碍中的作用。
Alzheimers Res Ther. 2017 Mar 4;9(1):16. doi: 10.1186/s13195-017-0240-3.
6
Metabolic Syndrome and the Risk of Mild Cognitive Impairment and Progression to Dementia: Follow-up of the Singapore Longitudinal Ageing Study Cohort.代谢综合征与轻度认知障碍及向痴呆进展的风险:新加坡纵向老龄化研究队列的随访。
JAMA Neurol. 2016 Apr;73(4):456-63. doi: 10.1001/jamaneurol.2015.4899.
7
The Minimum Clinically Important Difference in the Repeatable Battery for the Assessment of Neuropsychological Status.用于评估神经心理状态的可重复性成套测验中的最小临床重要差异。
Clin Neuropsychol. 2015;29(7):905-23. doi: 10.1080/13854046.2015.1107137. Epub 2015 Nov 7.
8
Predicting the risk of mild cognitive impairment in the Mayo Clinic Study of Aging.在梅奥诊所衰老研究中预测轻度认知障碍的风险。
Neurology. 2015 Apr 7;84(14):1433-42. doi: 10.1212/WNL.0000000000001437. Epub 2015 Mar 18.
9
Potential for primary prevention of Alzheimer's disease: an analysis of population-based data.阿尔茨海默病的一级预防潜力:基于人群数据分析。
Lancet Neurol. 2014 Aug;13(8):788-94. doi: 10.1016/S1474-4422(14)70136-X.
10
Normative data for the repeatable battery for the assessment of neuropsychological status in elderly Chinese.中国老年人神经心理状态评估可重复性成套测验的常模数据。
Arch Clin Neuropsychol. 2014 Aug;29(5):442-55. doi: 10.1093/arclin/acu023. Epub 2014 Jun 5.